MESENTERIC VASCULAR ANGIOTENSIN‐CONVERTING ENZYME IS INCREASED IN EXPERIMENTAL DIABETES MELLITUS

Karin Jandeleit, Jon Rumble, Bruce Jackson, Mark E. Cooper

Research output: Contribution to journalArticleResearchpeer-review

29 Citations (Scopus)

Abstract

1. Diabetes mellitus was induced by streptozotocin in male Wistar rats, and angiotensin‐converting enzyme measured in plasma and mesenteric vessels 3 weeks later. 2. Diabetes was associated with increased mesenteric wet weight/ bodyweight ratio (control 0.2 s.e.m. 0.02 mg/g, n= 21, vs diabetes 1.0 s.e.m. 0.3 mg/g, n= 27, P < 0.01, ANOVA). 3. Plasma angiotensin‐converting enzyme activity was increased in diabetic rats (98 s.e.m. 3 nmol HL/mL per min) compared with controls (64 s.e.m. 6 nmol HL/mL per min, P < 0.01, ANOVA). 4. Mesenteric vessel angiotensin‐converting enzyme was increased in diabetes mellitus estimated by radioligand binding site density (fmol/mg protein; 1407 s.e.m. 166 fmol/mg protein) compared with controls (890 s.e.m. 56 fmol/mg protein, P < 0.05, ANOVA) and by enzyme kinetic assay (diabetes, 15.5 s.e.m. 1.5 nmol HL/mg protein per min, controls, 8.3 s.e.m. 0.7 nmol HL/mg protein per min, P < 0.01, ANOVA). The equilibrium dissociation constant of ligand‐angiotensin‐converting enzyme interaction was unchanged. 5. Increased vascular angiotensin‐converting enzyme concentration may contribute to vascular hypertrophy and diabetic vasculopathy by increased local synthesis of angiotensin II.

Original languageEnglish
Pages (from-to)343-347
Number of pages5
JournalClinical and Experimental Pharmacology and Physiology
Volume19
Issue number5
DOIs
Publication statusPublished - May 1992
Externally publishedYes

Keywords

  • blood vessels
  • diabetes mellitus
  • renin‐angiotensin system.

Cite this